Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

December 31, 2011

Conditions
Cancer
Trial Locations (3)

2145

Westmead Hospital, Westmead

1105AZ

Academic medical center Amsterdam, Amsterdam

3075EA

Erasmus Medical Center, Daniel Den Hoed Cancer Center, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

South West Sydney Local Health District

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER